JR14a: A novel antagonist of C3aR attenuates neuroinflammation in cerebral ischemia-reperfusion injury

JR14a: A novel antagonist of C3aR attenuates neuroinflammation in cerebral ischemia-reperfusion injury

Cerebral ischemia-reperfusion injury (CIRI), a prevalent stroke-related complication, can lead to severe brain damage. Inflammation is a crucial factor in CIRI pathogenesis, and the complement component 3a receptor (C3aR) could be a key mediator in the post-CIRI inflammatory cascade. In this study,...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Jiutang Tang, Nueraili Maihemuti, Yu Fang, Junyi Tan, Mengjie Jia, Qinglan Mu, Keli Huang, Hui Gan, Jing Zhao
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Elsevier 2024-07-01
Sarja:Brain Research Bulletin
Aiheet:
Cerebral ischemia-reperfusion injury (CIRI)
JR14a
C3aR
Inflammation
Linkit:http://www.sciencedirect.com/science/article/pii/S0361923024001199

Internet

http://www.sciencedirect.com/science/article/pii/S0361923024001199

Samankaltaisia teoksia